Humanized mouse lines and their application for prediction of human drug metabolism and toxicological risk assessment
about
Ligand diversity of human and chimpanzee CYP3A4: activation of human CYP3A4 by lithocholic acid results from positive selectionPredicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical ModelsInnovative drugs to treat depression: did animal models fail to be predictive or did clinical trials fail to detect effects?Transgenic mice and metabolomics for study of hepatic xenobiotic metabolism and toxicityHumanizing π-class glutathione S-transferase regulation in a mouse model alters liver toxicity in response to acetaminophen overdoseModulation of CYP1A1 and CYP1A2 hepatic enzymes after oral administration of Chios mastic gum to male Wistar ratsRegulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.Glucuronidation of drugs and drug-induced toxicity in humanized UDP-glucuronosyltransferase 1 mice.Effects of ketoconazole on the biodistribution and metabolism of [11C]loperamide and [11C]N-desmethyl-loperamide in wild-type and P-gp knockout mice.A humanized UGT1 mouse model expressing the UGT1A1*28 allele for assessing drug clearance by UGT1A1-dependent glucuronidationComparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics.Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice.Development and characterization of a novel mouse line humanized for the intestinal peptide transporter PEPT1Bisphenol A increases atherosclerosis in pregnane X receptor-humanized ApoE deficient mice.Rapid induction of colon carcinogenesis in CYP1A-humanized mice by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate.Methodology to assay CYP2E1 mixed function oxidase catalytic activity and its inductionDose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamicsAn enhanced in vivo stable isotope labeling by amino acids in cell culture (SILAC) model for quantification of drug metabolism enzymes.Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity.Rodent models of alcoholic liver disease: of mice and men.Novel Transgenic Mouse Model for Studying Human Serum Albumin as a Biomarker of Carcinogenic ExposureCytochrome P450 2E1 potentiates ethanol induction of hypoxia and HIF-1α in vivoSubstituted diphenyl ethers as a broad-spectrum platform for the development of chemotherapeutics for the treatment of tularaemiaSulforaphane induces Nrf2 and protects against CYP2E1-dependent binge alcohol-induced liver steatosis.Long-term virus-induced alterations of CYP3A-mediated drug metabolism: a look at the virology, immunology and molecular biology of a multi-faceted problem.Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model.Nonviral gene transfer as a tool for studying transcription regulation of xenobiotic metabolizing enzymes.Cytochrome P450-mediated pulmonary metabolism of carcinogens: regulation and cross-talk in lung carcinogenesis.The early estimation of circulating drug metabolites in humans.Mouse models for liver cancer.Modulation of carcinogen-metabolizing cytochromes P450 by phytochemicals in humans.Chimeric rodents with humanized liver: bridging the preclinical/clinical trial gap in ADME/toxicity studies.Novel pre-clinical methodologies for pharmacokinetic drug-drug interaction studies: spotlight on "humanized" animal models.A comprehensive overview of hepatoprotective natural compounds: mechanism of action and clinical perspectives.The Use of Human Liver Cell Model and Cytochrome P450 Substrate-Inhibitor Panel for Studies of Dasatinib and Warfarin Interactions.A Pathway to Personalizing Therapy for Metastases Using Liver-on-a-Chip Platforms.Aryl hydrocarbon receptor (AHR): "pioneer member" of the basic-helix/loop/helix per-Arnt-sim (bHLH/PAS) family of "sensors" of foreign and endogenous signals.Current challenges and controversies in drug-induced liver injury.Species differences in drug glucuronidation: Humanized UDP-glucuronosyltransferase 1 mice and their application for predicting drug glucuronidation and drug-induced toxicity in humans.Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans.
P2860
Q24658486-F8D0F275-BCE0-44D0-8362-E32BA20BF040Q26764739-DF3209EF-2213-4F75-9AD2-BE75E6D23FC6Q26996411-D1CA93B6-E219-4E15-A1AC-B6ACA7C14081Q28087473-5749F78E-AD82-403B-AAC1-55D9C9AB5971Q28477445-E7ADD05D-9BE6-4CA8-81CD-395F96172E31Q28539891-234E5866-E05F-407D-AA16-EC68A69E7B6BQ33576459-8E8ADF5C-62CE-4403-9EDA-5075CA319F0EQ33742730-8F3E7751-47B8-41F4-BB82-797F42119E05Q33761780-55B696C4-FB1C-4409-A956-AB02EFF3C8D2Q33861874-F75A601D-6CA8-4E4D-A50D-DFA0CE86AA78Q34139167-756307A7-E98F-4588-8503-3E03B4B6888FQ34286764-FC2908D5-5A94-4FB4-8413-81ED4C599E2DQ34293583-B96929A7-09DA-43BF-8A8A-D4A00CF186ADQ34297158-13F8D9F9-F9EE-4F69-A314-7F56BA1888E1Q34520401-F0823369-BDD8-46C9-9E0A-442AE5234F39Q34980967-49CF1218-18F5-434A-9D5E-CEC5FAFCB75EQ35003666-6086C8AF-5C34-49DD-92FE-0C1C4C134D24Q35148413-6A9F4DB4-19D3-4445-8A5B-BD05FFDE0677Q35537187-4CD97CF9-A2AB-4173-832E-CB8DBDF78115Q36395131-5C025A6F-310E-43E2-86A9-73BC4B819BE9Q36905461-20BBAE4F-B4F2-4FB8-BE3A-D99C801C2A6AQ37060555-62022C93-800D-403B-ADB5-1DB405C5147DQ37383936-E6F5F15F-12C8-4216-A8A5-8C5CA1DDC65BQ37384563-49D7112C-1460-4076-BCC7-AB794613F535Q37592262-A0612E6C-05E6-4133-9C2A-560C0B7920EBQ37765653-303B4F5C-D52A-4D8D-A21C-BF2BDCC28D85Q37780317-500079DA-099B-4271-B414-60A148F114F8Q37811619-6A839880-0EBA-4616-9137-DEEF83B96A62Q38017286-564EB6F1-21D2-4D16-A637-CD876AB38FD4Q38083387-CDF6B545-CEE5-44B3-9AF8-58AAEB572E24Q38103296-86DC15E7-5738-4982-A16A-415D6E970FA4Q38169790-76489F5D-627A-43F7-BD17-A9192F77C93BQ38255685-E20D99AE-DF08-4448-BEB3-FE2A0DAEBEFAQ38588143-CAABAA8B-54EB-4664-B0D7-1DBC33B0901BQ38938055-D0652207-8300-46D4-AE15-0AD8CA7A3995Q39251464-09A80A24-ABC0-4E39-9C6C-E75160618DC1Q39367508-06B8D1E0-CD8F-4CA6-9820-9B7582685F0DQ39523252-E3752782-8772-4E8D-B303-7FCDE9B08488Q46273052-D875D3A9-0CA3-43B4-B384-B381153678DCQ46488398-74D1B9E1-DC95-4179-8EEB-D4269519F1AE
P2860
Humanized mouse lines and their application for prediction of human drug metabolism and toxicological risk assessment
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Humanized mouse lines and thei ...... toxicological risk assessment
@en
Humanized mouse lines and thei ...... toxicological risk assessment.
@nl
type
label
Humanized mouse lines and thei ...... toxicological risk assessment
@en
Humanized mouse lines and thei ...... toxicological risk assessment.
@nl
prefLabel
Humanized mouse lines and thei ...... toxicological risk assessment
@en
Humanized mouse lines and thei ...... toxicological risk assessment.
@nl
P2860
P921
P356
P1476
Humanized mouse lines and thei ...... toxicological risk assessment
@en
P2093
Connie Cheung
Frank J Gonzalez
P2860
P304
P356
10.1124/JPET.108.141242
P407
P577
2008-08-05T00:00:00Z
2008-11-01T00:00:00Z